Form D · Biotechnology
Memgen, Inc.
Houston, TX · CIK 0001760644
Offering snapshot reported Dec 10, 2024 · SEC filing
- Reported sold
- $950K Offering amount: $10M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 26, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 10, 2024 | Initial | $950,002 | No comparison | 2 | SEC filing |
| Jun 30, 2023 | Amendment | $624,979 | $0vs Nov 17, 2022 | 8 | SEC filing |
| Nov 17, 2022 | Initial | $624,979 | No comparison | 8 | SEC filing |
| Dec 14, 2021 | Amendment | $9,767,223 | $0vs Dec 13, 2021 | 60 | SEC filing |
| Dec 13, 2021 | Initial | $9,767,223 | No comparison | 60 | SEC filing |
| Jul 10, 2020 | Amendment | $575,000 | $525,000vs Jun 2, 2020 | 7 | SEC filing |
| Jul 10, 2020 | Amendment | $575,000 | $0vs Jul 10, 2020 | 7 | SEC filing |
| Jun 2, 2020 | Initial | $50,000 | No comparison | 1 | SEC filing |
| Sep 23, 2019 | Initial | $350,000 | No comparison | 3 | SEC filing |
| Dec 4, 2018 | Initial | $715,003 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-531572
Series A-2 Interests
Source: Form D, filed Dec 10, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Patricia Bitar | Director |
| Gregory Brown | Director, Executive |
| Mark Cantwell | Executive |
| Robert Coates | Director, Executive |
| Kevin Coveney | Executive |
| Casey Logan | Director |
| Christopher Pagano | Director |
| John Poulos | Director |
| Steven Whitley | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
12 Greenway Plaza Suite 1100
Houston, TX, 77046
Houston, TX, 77046